Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avalanche clause in effect

This article was originally published in The Tan Sheet

Executive Summary

FTC on April 24 says HeightMax maker Sunny Health Nutrition Technology & Products must pay its full $1.9 mil. redress for making false and unsubstantiated claims for three dietary supplements. In November, the Riverview, Fla.-based firm said it would pay $375,000 of the settlement agreement due to inability to pay the full amount (1"The Tan Sheet" Dec. 4, 2006, In Brief). However, the avalanche clause included in the settlement states the company must pay the entire $1.9 mil. if the firm misrepresented its finances. FTC said in December it discovered Sunny Health Nutrition possessed an undisclosed PayPal account containing more than $1.8 mil...

FTC on April 24 says HeightMax maker Sunny Health Nutrition Technology & Products must pay its full $1.9 mil. redress for making false and unsubstantiated claims for three dietary supplements. In November, the Riverview, Fla.-based firm said it would pay $375,000 of the settlement agreement due to inability to pay the full amount (1 'The Tan Sheet' Dec. 4, 2006, In Brief). However, the avalanche clause included in the settlement states the company must pay the entire $1.9 mil. if the firm misrepresented its finances. FTC said in December it discovered Sunny Health Nutrition possessed an undisclosed PayPal account containing more than $1.8 mil....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100441

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel